Excimer laser assisted angioplasty for the treatment of critical limb ischemia

John R. Laird, C. Reiser, G. Biamino, T. Zeller

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Two decades after the clinical introduction of percutaneous transluminal angioplasty (PTA), controversy still exists about the role of PTA for the treatment of occlusive disease in the femoropopliteal and infragenicular arteries. For the patient with critical limb ischemia (CLI), where diffuse disease and long occlusions are the rule, the results with PTA have not been optimal. Surgical revascularization has long been considered the gold standard for this patient population, but this procedure is associated with significant morbidity and mortality and up to 37% of patients may be poor surgical candidates. With advances in laser catheter design and refinement of recanalization techniques, improved results have been seen with laser assisted angioplasty of complex peripheral arterial disease. There has been renewed interest in excimer laser angioplasty for the treatment of patients with long total occlusions and diffuse disease who otherwise would have limited options for treatment. Excimer laser assisted angioplasty has been shown to be a successful approach to the treatment of long occlusions in the superficial femoral artery. Data from the recently completed Laser Angioplasty for Critical Limb Ischemia Phase 2 Trial (LACI) suggest that this is a liable treatment strategy for patients with CLI who are otherwise not good candidates for bypass surgery.

Original languageEnglish (US)
Pages (from-to)239-248
Number of pages10
JournalJournal of Cardiovascular Surgery
Volume45
Issue number3
StatePublished - Jun 2004
Externally publishedYes

Fingerprint

Laser-Assisted Balloon Angioplasty
Excimer Lasers
Ischemia
Extremities
Laser Angioplasty
Angioplasty
Therapeutics
Peripheral Arterial Disease
Femoral Artery
Lasers
Catheters
Arteries
Morbidity
Mortality
Population

Keywords

  • Angioplasty, balloon, laser assisted
  • Arterial occlusive disease
  • Ischemia
  • Leg

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Laird, J. R., Reiser, C., Biamino, G., & Zeller, T. (2004). Excimer laser assisted angioplasty for the treatment of critical limb ischemia. Journal of Cardiovascular Surgery, 45(3), 239-248.

Excimer laser assisted angioplasty for the treatment of critical limb ischemia. / Laird, John R.; Reiser, C.; Biamino, G.; Zeller, T.

In: Journal of Cardiovascular Surgery, Vol. 45, No. 3, 06.2004, p. 239-248.

Research output: Contribution to journalArticle

Laird, JR, Reiser, C, Biamino, G & Zeller, T 2004, 'Excimer laser assisted angioplasty for the treatment of critical limb ischemia', Journal of Cardiovascular Surgery, vol. 45, no. 3, pp. 239-248.
Laird, John R. ; Reiser, C. ; Biamino, G. ; Zeller, T. / Excimer laser assisted angioplasty for the treatment of critical limb ischemia. In: Journal of Cardiovascular Surgery. 2004 ; Vol. 45, No. 3. pp. 239-248.
@article{486528c9ff394e58966dcf35fe1f522f,
title = "Excimer laser assisted angioplasty for the treatment of critical limb ischemia",
abstract = "Two decades after the clinical introduction of percutaneous transluminal angioplasty (PTA), controversy still exists about the role of PTA for the treatment of occlusive disease in the femoropopliteal and infragenicular arteries. For the patient with critical limb ischemia (CLI), where diffuse disease and long occlusions are the rule, the results with PTA have not been optimal. Surgical revascularization has long been considered the gold standard for this patient population, but this procedure is associated with significant morbidity and mortality and up to 37{\%} of patients may be poor surgical candidates. With advances in laser catheter design and refinement of recanalization techniques, improved results have been seen with laser assisted angioplasty of complex peripheral arterial disease. There has been renewed interest in excimer laser angioplasty for the treatment of patients with long total occlusions and diffuse disease who otherwise would have limited options for treatment. Excimer laser assisted angioplasty has been shown to be a successful approach to the treatment of long occlusions in the superficial femoral artery. Data from the recently completed Laser Angioplasty for Critical Limb Ischemia Phase 2 Trial (LACI) suggest that this is a liable treatment strategy for patients with CLI who are otherwise not good candidates for bypass surgery.",
keywords = "Angioplasty, balloon, laser assisted, Arterial occlusive disease, Ischemia, Leg",
author = "Laird, {John R.} and C. Reiser and G. Biamino and T. Zeller",
year = "2004",
month = "6",
language = "English (US)",
volume = "45",
pages = "239--248",
journal = "Journal of Cardiovascular Surgery",
issn = "0021-9509",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Excimer laser assisted angioplasty for the treatment of critical limb ischemia

AU - Laird, John R.

AU - Reiser, C.

AU - Biamino, G.

AU - Zeller, T.

PY - 2004/6

Y1 - 2004/6

N2 - Two decades after the clinical introduction of percutaneous transluminal angioplasty (PTA), controversy still exists about the role of PTA for the treatment of occlusive disease in the femoropopliteal and infragenicular arteries. For the patient with critical limb ischemia (CLI), where diffuse disease and long occlusions are the rule, the results with PTA have not been optimal. Surgical revascularization has long been considered the gold standard for this patient population, but this procedure is associated with significant morbidity and mortality and up to 37% of patients may be poor surgical candidates. With advances in laser catheter design and refinement of recanalization techniques, improved results have been seen with laser assisted angioplasty of complex peripheral arterial disease. There has been renewed interest in excimer laser angioplasty for the treatment of patients with long total occlusions and diffuse disease who otherwise would have limited options for treatment. Excimer laser assisted angioplasty has been shown to be a successful approach to the treatment of long occlusions in the superficial femoral artery. Data from the recently completed Laser Angioplasty for Critical Limb Ischemia Phase 2 Trial (LACI) suggest that this is a liable treatment strategy for patients with CLI who are otherwise not good candidates for bypass surgery.

AB - Two decades after the clinical introduction of percutaneous transluminal angioplasty (PTA), controversy still exists about the role of PTA for the treatment of occlusive disease in the femoropopliteal and infragenicular arteries. For the patient with critical limb ischemia (CLI), where diffuse disease and long occlusions are the rule, the results with PTA have not been optimal. Surgical revascularization has long been considered the gold standard for this patient population, but this procedure is associated with significant morbidity and mortality and up to 37% of patients may be poor surgical candidates. With advances in laser catheter design and refinement of recanalization techniques, improved results have been seen with laser assisted angioplasty of complex peripheral arterial disease. There has been renewed interest in excimer laser angioplasty for the treatment of patients with long total occlusions and diffuse disease who otherwise would have limited options for treatment. Excimer laser assisted angioplasty has been shown to be a successful approach to the treatment of long occlusions in the superficial femoral artery. Data from the recently completed Laser Angioplasty for Critical Limb Ischemia Phase 2 Trial (LACI) suggest that this is a liable treatment strategy for patients with CLI who are otherwise not good candidates for bypass surgery.

KW - Angioplasty, balloon, laser assisted

KW - Arterial occlusive disease

KW - Ischemia

KW - Leg

UR - http://www.scopus.com/inward/record.url?scp=4043173482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043173482&partnerID=8YFLogxK

M3 - Article

C2 - 15179336

AN - SCOPUS:4043173482

VL - 45

SP - 239

EP - 248

JO - Journal of Cardiovascular Surgery

JF - Journal of Cardiovascular Surgery

SN - 0021-9509

IS - 3

ER -